Below are the most recent publications written about "Anthelmintics" by people in Profiles.
-
Ansdell V, Jacob J, Gosnell WL, McMillan JKP, Yates J, Lteif L, Bicakci D, Kaufusi PH, Kramer K. An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai'i: Evidence Supporting the Early Use of Albendazole-Corticosteroid Co-Therapy. Am J Trop Med Hyg. 2026 May 06; 114(5):930-936.
-
Leas DA, Keiser J, Charman SA, Shackleford DM, Jones JO, Campbell M, Chen G, Katneni K, Patil R, Hu M, Pham T, H?berli C, Schulze TT, Neville AJ, Wang X, Dong Y, Davis PH, Vennerstrom JL. Single-Dose Drug Development Candidate for Schistosomiasis. ACS Infect Dis. 2024 11 08; 10(11):3963-3972.
-
Mertelsmann AM, Bowers SF, Wright D, Maganga JK, Mazigo HD, Ndhlovu LC, Changalucha JM, Downs JA. Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review. PLoS Negl Trop Dis. 2024 Sep; 18(9):e0012456.
-
Jacob J, Siraj MA, Steel A, Tan G, Jarvi S. Evaluation of the mechanism of action of albendazole on adult rat lungworm (Angiostrongyluscantonensis). Exp Parasitol. 2022 Nov; 242:108355.
-
Jacob J, Steel A, Kaluna L, Hess S, Leinbach I, Antaky C, Sugihara R, Hamilton L, Follett P, Howe K, Jacquier S, Wongwiwatthananukit S, Jarvi S. In vivo efficacy of pyrantel pamoate as a post-exposure prophylactic for rat lungworm (Angiostrongylus cantonensis). Int J Parasitol Drugs Drug Resist. 2022 08; 19:1-5.
-
Jacob J, Steel A, Lin Z, Berger F, Z?eller K, Jarvi S. Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies. Clin Infect Dis. 2022 04 09; 74(7):1293-1302.
-
Sutar Y, Fulton SR, Paul S, Altamirano S, Mhatre S, Saeed H, Patel P, Mallick S, Bhat R, Patravale VB, Chauhan H, Nielsen K, Date AA. Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. ACS Infect Dis. 2021 09 10; 7(9):2637-2649.
-
Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
-
Odani J, Sox E, Coleman W, Jha R, Malik R. First Documented Cases of Canine Neuroangiostrongyliasis Due to Angiostrongylus cantonensis in Hawaii. J Am Anim Hosp Assoc. 2021 Jan 01; 57(1):42-46.
-
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705.